The Social Media Spiral into Unregulated Weight-Loss Peptides
It often begins with a single Instagram reel. A fitness influencer meticulously dissects the advantages and drawbacks of the market's most potent weight-loss peptides. With just two taps, the algorithm swiftly takes control, flooding feeds with peptide-fueled weight-loss journey posts. This initial exposure leads users down a rabbit hole, hunting for lengthy YouTube explainers that delve deeper into the subject.
The path is paved with AI-simplified scientific papers, obsessive Reddit threads, and private chat groups. All of this builds toward a critical final act: receiving a shipment from China containing powdered weight-loss medication that is unapproved and still under clinical trials.
The Desperate Hunt for Alternatives
Across India, hundreds rely on these imports, partly to circumvent the high costs of doctor-prescribed medications like Mounjaro, which can reach Rs 16,000 per month. While Semaglutide, known by the brand name Ozempic, has become more affordable, it fails to curb the demand for "Chinese peptides." The primary attraction lies in a desperate search for alternatives that delay the weight-loss plateau. Even the most potent GLP-1 medications can only reduce weight to a certain extent, as the gut eventually adapts. Upon discontinuation, weight often slowly rebounds.
A Reddit group named 'r/Retatrutide' attracts 156,000 weekly visitors globally. This experimental injectable medication mimics three hormones—GLP-1, GIP, and glucagon—and has shown greater promise for weight loss in clinical trials than its predecessors.
Personal Stories from the Underground
"Anyone from India? I am very new to peptides and wanna talk with an Indian guy running Reta...," posted one user months ago on r/Retatrutide. Recently, another user, Tarun (name changed), commented on the post: "I'm trying to find legit sources for Reta here but I'm not able to." He soon announced to the group that he had found a source.
Many others are similarly attempting to acquire Retatrutide. At KEM Hospital, Dr. Tushar Bandgar recalled a perplexing moment when a patient sent an internet-downloaded image of a box labelled Retatrutide, asking if it was safe to consume. "We told him it is unapproved for use," said Dr. Bandgar.
Tarun, a 20-year-old resident of Grant Road, Mumbai, has struggled with obesity since his teens. "By 15, I just wanted to lose weight. I started learning about calories, micronutrients, and protein," he explained. A gym membership at 17 helped him lose 10 to 15 kg, bringing his weight down to around 80 kg in a year, but progress stalled thereafter.
Last year, the world of peptides inundated his screen during random doom-scrolling sessions. He researched Tesamorelin (used to reduce excess abdominal fat, primarily in HIV patients), Ipamorelin (for muscle growth), MOT-C (for metabolic efficiency), and TB-500 (for muscle repair). Ultimately, he settled on Retatrutide: "I am a huge fan," he said. This Monday, he began a 1mg weekly dose, paying Rs 11,000 for 50mg after a "student discount."
Meanwhile, Javed (name changed), a 41-year-old photographer from Kharghar, was already injecting Retatrutide for weight loss, along with Tesamorelin and Ipamorelin. The buzz around Ozempic introduced him to GLP-1 medications, leading him to explore more niche peptides. Ten vials of Retatrutide (10mg each) cost him Rs 10,000, yielding 5 mg injections weekly.
The Seller's Perspective
Tarun's Bengaluru-based seller, Ranjan (22, name changed), who boasts a client base of 200, also struggled with obesity for years. His first attempt to import Retatrutide ended in a scam. "I injected 20 mg over 45 days, but nothing happened," he said. Through Reddit, he quickly found reliable vendors. As a seller, he makes the terms clear: "I tell them that the dosage is their lookout and the supplies are mine."
His website carries a disclaimer: "Products sold are strictly for in-vitro research and analytical applications. They are not intended for human consumption or medical use..."
Expert Warnings and Unknown Risks
Such unsupervised and surreptitious use of these chemicals is raising alarm bells among experts. Endocrinologist Dr. Nikhil Bhagwat expressed concern, noting that people are injecting multiple peptides simultaneously. "I'm not sure if the combination of Retatrutide and Tesamorelin has ever been studied," he said.
The long-term risks of Retatrutide remain unknown because it is still under trial. "GLP-1s are life-saving, but our understanding is still developing. Some on Semaglutide or Tirzepatide have only now begun reporting depression or gastroparesis," Dr. Bhagwat added.
Navigating Legal Loopholes
A user-turned-seller, Ankit (31, name changed) from Gurgaon, said his weekly imports always exceed $500. He offers customers two options: club their order with his to bypass the $50 shipping charge or buy directly from his stock as needed. Payments to Chinese vendors are made in cryptocurrency.
Through online groups, Ankit estimates he is part of a circle of at least 100 Retatrutide users in India. Having struggled with obesity himself, he began importing peptides last year but realized it was unsustainable without a business model. A 40% profit on sales allows him to reinvest funds into more purchases for himself and others.
The scale of this operation is significant: 50 to 60 import orders of peptides for consumption and sales—totaling 5,000 vials labelled "research use" worth over Rs 20 lakh annually—all slip past customs through cargo shipments.
Ankit explained the import process: small boxes arrive with abbreviated compound names. Vendors send these to freight forwarders who combine them with larger shipments of unrelated products. Commercial invoices are attached, and the goods are handed over to courier services.
"In the declaration, only a few products, their quantity, and value are mentioned. When it reaches India, bare-minimum screening is done by Customs before release," Ankit said. One of his orders was opened for the first time just weeks ago and still made it through.
A Customs official explained that India's trade facilitation policy aims to expedite cargo clearance to ease business operations. A computerized Risk Management System (RMS) profiles consignments as low, medium, or high risk. Low-risk items are 'facilitated' without further assessment or physical examination.
Growing 'Risk Appetite' Among Users
Emboldened by social media validation, consumers and sellers claim they understand the dangers of unregulated medication. They assert that one must have a "risk appetite" because they can "never be sure what they're consuming."
Concerns about dosage or proportions occasionally surface in online forums. Users on r/Retatrutide sometimes ask if a red cap indicates 10 mg or if blue means 5 mg, and whether a color signifies a "good" or "bad" batch. "Stop with this nonsense," one user reacted. Another clarified: "Colour of caps means nothing and indicates nothing."
Users also form private groups to coordinate lab testing. They purchase Chinese peptide kits from the same vendor simultaneously to test and share results publicly. "Good results are valid for a short timeframe. They don't hold true two months later," Ankit noted.
A Global Phenomenon
In 2025, imports of Chinese hormones and peptides to the US—primarily in Silicon Valley—doubled to $328 million, according to US Customs figures cited by American media. Similar trends have been documented in the UK. "The whole world imports this stuff from China, not just India," says Ranjan, highlighting the widespread nature of this issue.
